The HBA’s Tomorrow’s Executives affinity group, with the support of Bristol Myers Squibb, offers this four-part series to connect you with future and current leaders of top biopharmaceutical companies. These webinars (scheduled from September 9 through October 16, 2020) will highlight the achievements of the next generation across the industry and underscore the importance of their contributions to their organization, and beyond. Join us as we explore: social intrapreneurship, diversity in clinical trials, COVID-19 responses, and how young professionals are impacting the future of work.

This panel discussion will feature the top minds in infectious diseases, virology and vaccinology, who will give participants a breakdown of the top vaccine candidates and the latest information on clinical trials.

During this webinar, learn more about benefits and risks of changing primary components during product development and how a design of experiments approach can be used to address issues and risks.

This webinar will share information on the influence of multimillion-dollar pharmaceutical costs, along with successful cost containment practices demonstrated through case studies of effective intervention.

Join the Marken team and industry experts to learn about new supply chain industry trends and how companies can prepare to move clinical trials forward post-pandemic.

Topics covered in this webinar will include robust, sensitive, & easy-to-use cell-based, reporter gene assays to study signaling pathways.

This webinar will discuss a set of in vitro assays that tackle the challenges of in vitro hepatotoxicity assessment.

Businesses, professional bodies and individual practitioners have to keep talking at a time like this, not least because patients’ non-Covid-related needs have not disappeared overnight. How are lines of communication holding up, and what might this tell us about life after Covid-19?

Summary Payment Integrity amidst COVID-19: A Health Plan Perspective Date: Thursday, June 11, 2020 Time: 01:00 PM, EDT Duration: 1 hour Register Now COVID-19 is having a profound impact on […]

Join the HBA for a special virtual discussion led by Dr. Zeev Neuwirth, MD, as he addresses how the COVID-19 pandemic has served as a catalyst for re-framing healthcare.